Biogen's total costs and expenses 2014-2023
This statistic shows the total costs and expenses for Biogen from 2014 to 2023, in million U.S. dollars. According to the company, operating costs and expenses increased from 5.75 billion U.S. dollars in 2014 to 9.2 billion U.S. dollars in 2021, the highest amount so far. However, costs and expenses were lower in 2022 and 2023. Biogen Inc. is a Massachusetts-based biotech company, specialized in drugs for neurological disorders, autoimmune disorders and cancer.